ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.
复制标题
DOI：
10.1186/s13601-016-0137-4
复制
发表时间：
2016
影响因子：
4.4
通讯作者：
Zidarn M
中科院分区：
文献类型：
--
作者：
Bousquet J;Hellings PW;Agache I;Bedbrook A;Bachert C;Bergmann KC;Bewick M;Bindslev-Jensen C;Bosnic-Anticevitch S;Bucca C;Caimmi DP;Camargos PA;Canonica GW;Casale T;Chavannes NH;Cruz AA;De Carlo G;Dahl R;Demoly P;Devillier P;Fonseca J;Fokkens WJ;Guldemond NA;Haahtela T;Illario M;Just J;Keil T;Klimek L;Kuna P;Larenas-Linnemann D;Morais-Almeida M;Mullol J;Murray R;Naclerio R;O'Hehir RE;Papadopoulos NG;Pawankar R;Potter P;Ryan D;Samolinski B;Schunemann HJ;Sheikh A;Simons FE;Stellato C;Todo-Bom A;Tomazic PV;Valiulis A;Valovirta E;Ventura MT;Wickman M;Young I;Yorgancioglu A;Zuberbier T;Aberer W;Akdis CA;Akdis M;Annesi-Maesano I;Ankri J;Ansotegui IJ;Anto JM;Arnavielhe S;Asarnoj A;Arshad H;Avolio F;Baiardini I;Barbara C;Barbagallo M;Bateman ED;Beghé B;Bel EH;Bennoor KS;Benson M;Białoszewski AZ;Bieber T;Bjermer L;Blain H;Blasi F;Boner AL;Bonini M;Bonini S;Bosse I;Bouchard J;Boulet LP;Bourret R;Bousquet PJ;Braido F;Briggs AH;Brightling CE;Brozek J;Buhl R;Bunu C;Burte E;Bush A;Caballero-Fonseca F;Calderon MA;Camuzat T;Cardona V;Carreiro-Martins P;Carriazo AM;Carlsen KH;Carr W;Cepeda Sarabia AM;Cesari M;Chatzi L;Chiron R;Chivato T;Chkhartishvili E;Chuchalin AG;Chung KF;Ciprandi G;de Sousa JC;Cox L;Crooks G;Custovic A;Dahlen SE;Darsow U;Dedeu T;Deleanu D;Denburg JA;De Vries G;Didier A;Dinh-Xuan AT;Dokic D;Douagui H;Dray G;Dubakiene R;Durham SR;Du Toit G;Dykewicz MS;Eklund P;El-Gamal Y;Ellers E;Emuzyte R;Farrell J;Fink Wagner A;Fiocchi A;Fletcher M;Forastiere F;Gaga M;Gamkrelidze A;Gemicioğlu B;Gereda JE;van Wick RG;González Diaz S;Grisle I;Grouse L;Gutter Z;Guzmán MA;Hellquist-Dahl B;Heinrich J;Horak F;Hourihane JO;Humbert M;Hyland M;Iaccarino G;Jares EJ;Jeandel C;Johnston SL;Joos G;Jonquet O;Jung KS;Jutel M;Kaidashev I;Khaitov M;Kalayci O;Kalyoncu AF;Kardas P;Keith PK;Kerkhof M;Kerstjens HA;Khaltaev N;Kogevinas M;Kolek V;Koppelman GH;Kowalski ML;Kuitunen M;Kull I;Kvedariene V;Lambrecht B;Lau S;Laune D;Le LT;Lieberman P;Lipworth B;Li J;Lodrup Carlsen KC;Louis R;Lupinek C;MacNee W;Magar Y;Magnan A;Mahboub B;Maier D;Majer I;Malva J;Manning P;De Manuel Keenoy E;Marshall GD;Masjedi MR;Mathieu-Dupas E;Maurer M;Mavale-Manuel S;Melén E;Melo-Gomes E;Meltzer EO;Mercier J;Merk H;Miculinic N;Mihaltan F;Milenkovic B;Millot-Keurinck J;Mohammad Y;Momas I;Mösges R;Muraro A;Namazova-Baranova L;Nadif R;Neffen H;Nekam K;Nieto A;Niggemann B;Nogueira-Silva L;Nogues M;Nyembue TD;Ohta K;Okamoto Y;Okubo K;Olive-Elias M;Ouedraogo S;Paggiaro P;Pali-Schöll I;Palkonen S;Panzner P;Papi A;Park HS;Passalacqua G;Pedersen S;Pereira AM;Pfaar O;Picard R;Pigearias B;Pin I;Plavec D;Pohl W;Popov TA;Portejoie F;Postma D;Poulsen LK;Price D;Rabe KF;Raciborski F;Roberts G;Robalo-Cordeiro C;Rodenas F;Rodriguez-Mañas L;Rolland C;Roman Rodriguez M;Romano A;Rosado-Pinto J;Rosario N;Rottem M;Sanchez-Borges M;Sastre-Dominguez J;Scadding GK;Scichilone N;Schmid-Grendelmeier P;Serrano E;Shields M;Siroux V;Sisul JC;Skrindo I;Smit HA;Solé D;Sooronbaev T;Spranger O;Stelmach R;Sterk PJ;Strandberg T;Sunyer J;Thijs C;Triggiani M;Valenta R;Valero A;van Eerd M;van Ganse E;van Hague M;Vandenplas O;Varona LL;Vellas B;Vezzani G;Vazankari T;Viegi G;Vontetsianos T;Wagenmann M;Walker S;Wang DY;Wahn U;Werfel T;Whalley B;Williams DM;Williams S;Wilson N;Wright J;Yawn BP;Yiallouros PK;Yusuf OM;Zaidi A;Zar HJ;Zernotti ME;Zhang L;Zhong N;Zidarn M
过敏性鼻炎及其对哮喘的影响(ARIA)倡议始于1999年世界卫生组织的一个研讨会。最初的目标是(1)提出新的过敏性鼻炎分类，(2)促进哮喘和鼻炎的多种发病率的概念，以及(3)与所有利益攸关方共同制定可在全球范围内适用于所有国家和人口的指南。ARIA--在全球70多个国家传播和实施--现在正专注于实施个性化和预测性医学的新兴技术。MACVIA[MACVIA(防治疾病编年史活动)-ARIA哨兵网络]使用移动技术开发护理路径，由多学科小组和患者自己管理鼻炎和哮喘。一款应用程序(Android和iOS)在20个国家和15种语言中可用。它使用可视模拟标尺来评估症状控制和工作效率，以及临床决策支持系统。它与医生和其他医疗保健专业人员的可互操作平板电脑相关。扩大规模战略使用了欧洲创新伙伴关系关于积极和健康老龄化的建议。新的ARIA方法的目的是为鼻炎患者提供积极和健康的生活，无论他们的年龄、性别或社会经济地位如何，以减少这种疾病造成的健康和社会不平等。
The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA—disseminated and implemented in over 70 countries globally—is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA (Contre les Maladies Chroniques pour un Vieillissement Actif)-ARIA Sentinel NetworK] uses mobile technology to develop care pathways for the management of rhinitis and asthma by a multi-disciplinary group and by patients themselves. An app (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease.
登录
查看更多内容
影响因子：
10
作者：
Bousquet J;Anto JM;Berkouk K;Gergen P;Antunes JP;Augé P;Camuzat T;Bringer J;Mercier J;Best N;Bourret R;Akdis M;Arshad SH;Bedbrook A;Berr C;Bush A;Cavalli G;Charles MA;Clavel-Chapelon F;Gillman M;Gold DR;Goldberg M;Holloway JW;Iozzo P;Jacquemin S;Jeandel C;Kauffmann F;Keil T;Koppelman GH;Krauss-Etschmann S;Kuh D;Lehmann S;Carlsen KC;Maier D;Méchali M;Melén E;Moatti JP;Momas I;Nérin P;Postma DS;Ritchie K;Robine JM;Samolinski B;Siroux V;Slagboom PE;Smit HA;Sunyer J;Valenta R;Van de Perre P;Verdier JM;Vrijheid M;Wickman M;Yiallouros P;Zins M
通讯作者：
Zins M
影响因子：
14.2
作者：
Anto, Josep M.;Pinart, Mariona;Bousquet, Jean
通讯作者：
Bousquet, Jean
影响因子：
7.2
作者：
Blanc, PD;Trupin, L;Yelin, EH
通讯作者：
Yelin, EH
影响因子：
2.8
作者：
Bousquet, Jean;Bachert, Claus;Zuberbier, Torsten
通讯作者：
Zuberbier, Torsten
在过敏性疾病中铺平系统生物学和精确医学的方式：奖章的成功故事：过敏的发展机制；欧盟FP7-CP-IP;项目编号：261357； 2010-2015。
影响因子：
12.4
作者：
Bousquet J;Anto JM;Akdis M;Auffray C;Keil T;Momas I;Postma DS;Valenta R;Wickman M;Cambon-Thomsen A;Haahtela T;Lambrecht BN;Lodrup Carlsen KC;Koppelman GH;Sunyer J;Zuberbier T;Annesi-Maesano I;Arno A;Bindslev-Jensen C;De Carlo G;Forastiere F;Heinrich J;Kowalski ML;Maier D;Melén E;Palkonen S;Smit HA;Standl M;Wright J;Asarnoj A;Benet M;Ballardini N;Garcia-Aymerich J;Gehring U;Guerra S;Hohman C;Kull I;Lupinek C;Pinart M;Skrindo I;Westman M;Smagghe D;Akdis C;Albang R;Anastasova V;Anderson N;Bachert C;Ballereau S;Ballester F;Basagana X;Bedbrook A;Bergstrom A;von Berg A;Brunekreef B;Burte E;Carlsen KH;Chatzi L;Coquet JM;Curin M;Demoly P;Eller E;Fantini MP;Gerhard B;Hammad H;von Hertzen L;Hovland V;Jacquemin B;Just J;Keller T;Kerkhof M;Kiss R;Kogevinas M;Koletzko S;Lau S;Lehmann I;Lemonnier N;McEachan R;Mäkelä M;Mestres J;Minina E;Mowinckel P;Nadif R;Nawijn M;Oddie S;Pellet J;Pin I;Porta D;Rancière F;Rial-Sebbag A;Saeys Y;Schuijs MJ;Siroux V;Tischer CG;Torrent M;Varraso R;De Vocht J;Wenger K;Wieser S;Xu C
通讯作者：
Xu C